Halifax, NS – Cancer Care Nova Scotia and Capital Health have established the Roche Fellowship in Clinical Oncology. The new fellowship is the result of a $225,000 donation from Hoffman LaRoche.
The donation provides funding for the recruitment and salary costs of one clinical research fellow, in each of the next three years, to join the medical oncology team at Dalhousie University’s Faculty of Medicine and Capital Health.
“A strong clinical research program is pivotal to high quality cancer treatment and care,” says Dr Andrew Padmos, commissioner, Cancer Care Nova Scotia. “This generous donation from Roche will enable us to further strengthen cancer research in Nova Scotia and build our body of knowledge in such areas as lymphoma, lung, breast and gastro-intestinal cancers.”
Roche Clinical Research Fellows will be newly certified cancer specialists who opt to enhance their training and qualifications by completing a focused ‘fellowship’ year of concentrated clinical activity and mentored research.
The clinical and research activities of the first Roche Clinical Research Fellow will focus on breast cancer.